honors & awards

Dr.  Maky Zanganeh has been honored with many awards. Maky is currently the Co-Chief Executive Officer and President, as well as a member of the board, at Summit Therapeutics – a company committed to optimizing human health. She previously served as Summit’s Chief Operating Officer, from the time she joined the company in November 2020.

Prior to that, as Chief Operating Officer at Pharmacyclics, she led a struggling biotech company to a multimillion-dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc. in 2011 and, the subsequent sale of the company for $21 billion dollars in 2015 to AbbVie Inc.- the second largest biopharma sale ever in the industry.  The deal with Janssen Biotech received the award of the “Best Biotech Transaction” in 2011.  Under her leadership in 2015, Pharmacyclics was also awarded the prestigious Prix Galien for “Best Pharmaceutical Agent”.  This award is the biomedical industry’s highest accolade and recognizes outstanding achievements in the development of new therapies. 

Maky is an honored speaker of the United Nations, recently speaking during the closing ceremony during the United Nations February 11 Global Movement held on February 11, 2022. Dr. Zanganeh was President of EMEA / Global VP of Training and Education for Computer Motion, Inc. (Pioneers in Robotic Surgery) which later merged with Intuitive, Inc. (ISRG) company in June 2003.  Dr. Zanganeh was awarded her DDS (Dental Degree of Surgery) from the Louis Pasteur University, France and an MBA from Schiller International University, France. She is fluent in French, German, Farsi, and English. Dr Zanganeh earned the Fierce Biotech “2013 Top women in biotech” award, and the E&Y company “Entrepreneur of the Year” 2013 award.  She is also a published author, recently releasing her book entitled The Magic of Normal.